Sequenta, Inc. Company Profile
Sequenta, Inc. is a privately held company developing and commercializing molecular diagnostic assays based on a proprietary sequencing approach to the profiling of T and B cell receptor repertoires. The incredible diversity created by these genes is at the heart of a large number of conditions critical to human health and disease.
News Articles
SWOG to deploy Sequenta LymphoSIGHT platform
SWOG (formerly the Southwest Oncology Group) has chosen Sequenta's LymphoSIGHT platform for the measurement of minimal residual disease (MRD) in 180-patient mantle cell lymphoma clinical trial.
Eastern to use Sequenta LymphoSIGHT method in E1411 phase II trial
Eastern Cooperative Oncology Group, now a part of the ECOG-ACRIN Cancer Research Group, has entered into an agreement to use Sequenta's new LymphoSIGHT sequencing method in its randomized E1411 phase...
Sequenta sales and marketing update
Sequenta, Inc. announced today that SWOG has selected Sequenta’s LymphoSIGHT™ platform for the measurement of Minimal Residual Disease (MRD) in a clinical trial....
Sequenta, Inc. announced today that data demonstrating the power of its DNA sequencing-based LymphoSIGHTTM platform for the detection of Minimal Residual Disease (MRD) was present...
Sequenta, Inc. announced today the commercial launch of ClonoSIGHT™, the first sequencing-based test for minimal residual disease (MRD) for leukemia and lymphoma. The ClonoSIGHT...
Sequenta, Inc. and their collaborators presented data from four new clinical studies in which the LymphoSIGHT™ method demonstrated superior sensitivity in measuring minimal resi...
Sequenta’s LymphoSIGHT™ Platform Included in Phase II Mantle Cell Lymphoma Clinical Trial
Sequenta, Inc. and the Eastern Cooperative Oncology Group (now part of the ECOG-ACRIN Cancer Research Group) today announced an agreement to use Sequenta’s LymphoSIGHT™ next-g...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
Sequenta, Inc. is a privately held company developing and commercializing molecular diagnostic assays based on a proprietary sequencing approach to the profiling of T and B cell r...
More Information about "Sequenta, Inc." on BioPortfolio
We have published hundreds of Sequenta, Inc. news stories on BioPortfolio along with dozens of Sequenta, Inc. Clinical Trials and PubMed Articles about Sequenta, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sequenta, Inc. Companies in our database. You can also find out about relevant Sequenta, Inc. Drugs and Medications on this site too.
